Alzheimer’s disease, which is one of the most common forms of dementia, affects millions worldwide, and early detection has ...

Australia's drug and therapeutic regulatory agency has approved the first drug for treatment of Alzheimer's disease, public ...

New drug helps slow progression of Alzheimer's Works by clearing abnormal proteins from the brain READ MORE: Sudden diet ...

The Therapeutic Goods Administration has approved a new drug tipped to revolutionise the treatment of hundreds of thousands of Australians suffering through early-stage Alzheimer’s disease.

Join us to learn about dementia and understand the difference between normal aging and memory loss at our free community ...

Dementia Australia welcomes the Therapeutic Goods Administration (TGA) registration of Kisunla (donanemab), for use in ...

A drug that is given once a month to slow the cognitive decline associated with Alzheimer’s disease has been approved by the TGA, but will only be available for a select few who can afford it ...

The blood test is used to detect abnormal protein deposits in the brain that are associated with Alzheimer's. The test is for people 55 and older who are already showing signs of the disease, ...

Recently, the Food and Drug Administration approved a blood test that can help diagnose the disease —by detecting amyloid ...

Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia.

It’s in your medicine cabinet, it’s easy to overuse—and experts say the long-term consequences could be serious.

Treating cold sores with anti-viral medicines could help slash the risk of Alzheimer’s disease, research suggests. Previous ...